Successful Acquisitions
JUNE 27, 2023
Will Cava Going Public Set the Table for Other IPOs? By David Braun, Founder and CEO, Capstone Strategic When Washington DC based restaurant chain Cava became a publicly traded company recently, it bucked a trend that has lasted nearly two years, a notable absence of American IPOs.
TechCrunch: M&A
MAY 8, 2023
Content needs to be engaging and entertaining and you need to be recommended the right thing at the right time to keep you going. Barnes said that an IPO was part of the long-term plan but that “it’s not something we are targeting right now.” .” But there is still something missing in those takes, he continued.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mergers and Inquisitions
OCTOBER 4, 2023
There are some entertaining moments and good performances, so I wouldn’t call the movie “bad.” Everyone was locked up inside, and many turned to day trading for entertainment and money (in between binge-watching shows on streaming services). I wrote many articles about it. Remember when Chamath was on CNBC all the time ?
CNBC: Investing
JULY 8, 2025
" Bernstein initiated research coverage of the Chinese online entertainment services provider with an outperform rating and a $28 per share price target. "In a world where short form videos and quality are variable at best, there is a place for a platform with refreshing content." BILI YTD mountain Bilibili stock in 2025.
CNBC: Investing
JUNE 26, 2025
The company went public to a great deal of fanfare in March of 2021 during the IPO bubble. Risk management Josh here — CPNG, despite its rally this year, is still in a 40% drawdown from the '21 peak despite the fact that it is now a much bigger, more successful business than it was at the time of its IPO. Until now.
Cooley M&A
NOVEMBER 1, 2018
government shutdown disrupting the market for IPOs, Brexit uncertainty, natural disasters and various other crises, cross-border M&A activity momentum continues. In spite of a general environment of political and economic uncertainty and a daily sprinkling of stock market volatility, trade wars, sanctions, the U.S. Finally, with the U.K.
Cooley M&A
JANUARY 25, 2023
Although there were 104 initial public offerings of biotechnology companies in 2021 that raised nearly $15 billion in funds, 2022 saw only 22 such IPOs collectively raising less than $2 billion. Let’s dig in.
Expert insights. Personalized for you.
111 
Let's personalize your content